ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176503; 2) Community: the network communities that were significantly associated with the response to NSC 176503; 3) Molecule: the relationships between components within communities and NSC 176503; 4) MDR: the compounds that were significantly associated with the NSC 176503.

NSC Compound Enrichment Correlation
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.00010455364200097 0.56118222
NSC 627744 Null 0.00010455364200097 0.62775139
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.00010455364200097 0.54812694
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 0.00010455364200097 0.64800847
NSC 639981 Null 0.00010455364200097 0.63355879
NSC 79304 Null 0.00010455364200097 0.58352696
NSC 750341 7,8-dihydroxyflavone 0.000108967261726037 0.3280332
NSC 158036 1,2-Benzisothiazoline-3-thione, 2-methyl- (8CI) 0.000141616984257996 0.6869763
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.000141616984257997 0.56217398
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.000141616984257997 0.43114971
Total:176  Current:1    [First] [Prev] [Next] [Last]